Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

332 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    China's New Policies On Foreign Investment In Healthcare And Biotechnology

    In early September 2024, China announced two significant policy changes aimed at further opening its healthcare and biotechnology sectors to foreign investment.
    ChinaGovernment, Public Sector
    Lusheng Law Firm
    Lusheng Law Firm
  • Article

    Navigating China's Health Transformation: Opportunities And Challenges For Multinationals

    With the core goal of achieving health equity by 2030 — meaning the elimination of health disparities to give all Chinese citizens a fair opportunity to be healthy — Healthy China 2030 stands...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ankura Consulting Group LLC
    Ankura Consulting Group LLC
Article

The New Regulations On Medical Aesthetics Came Into Effect Today - The Supervision Of Radio Frequency Beauty Devices Such As Thermage And Heatlifter Has Been Upgraded

Today (April 1), the new regulations of the State Medical Products Administration ("NMPA") on the inclusion of radio frequency therapy devices and RF...
ChinaFood, Drugs, Healthcare, Life Sciences
Han Kun Law Offices
Han Kun Law Offices
  • Article

    Judicial Assessment Of Usage Limitations' Impact On The Novelty Of Product Claims

    The SPC pointed out in an administrative appeal that, for product claims containing a subject name with usage limitation, the usage limitation must be considered when determining the scope of protection.
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    Cosmetics Advertising In China

    In November, it was reported that L‘oreal (China) Co., Ltd. was fined RMB 200,000 for a printed advertisement posted in a shopping mall.
    ChinaMedia, Telecoms, IT, Entertainment
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    Food Advertising In China: "Do's And Don'ts" From Recent Cases

    Chinese society pays increasing attention to food safety. Recently, a "double standards" scandal erupted when it was publicized that food company Haitian's soy sauce sold overseas had fewer additives...
    ChinaMedia, Telecoms, IT, Entertainment
    Global Advertising Lawyers Alliance (GALA)
    Global Advertising Lawyers Alliance (GALA)
  • Article

    改革动作频频,千亿医疗器械市场面临机遇和挑战

    近几个月来医疗器械行业内改革动作频频。医疗器械注册人制度试点扩大到21个省,有如释放行业创新活力的一剂良方,监管方通过将产研分开&#
    ChinaFood, Drugs, Healthcare, Life Sciences
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    What Does The Third Amendment To China´s Patent Law Mean To Pharmaceutical Companies?

    Since its enactment in 1984, China's Patent Law has been amended twice, first in 1992 and then in 2000. The first amendment added pharmaceutical compositions to the list of patentable subject matter and inaugurated China's membership in the Patent Cooperation Treaty ("PCT").
    ChinaIntellectual Property
    Jones Day
    Jones Day
  • Article

    Revised Chinese Patent Examination Guidelines Toke Effect From 15 January, 2021

    The China National Intellectual Property Administration ("CNIPA") recently announced the "Revised Patent Examination Guidelines", which came into force from January 15, 2021.
    ChinaIntellectual Property
    Foundin Intellectual Property
    Foundin Intellectual Property
  • Article

    China Continues To Sharpen Its Teeth Against Corruption: Updates To China's Anti-Corruption Regime

    The first half of 2018 saw a number of significant changes to the Chinese anti-corruption regime, including amendments to the Anti-Unfair Competition Law and formation of new anti-corruption regulatory bodies.
    ChinaCriminal Law
    Reed Smith (Worldwide)
    Reed Smith (Worldwide)
  • Article

    China Life Sciences: 2025 Year In Review

    2025 was a year of notable developments for China's life sciences industry, marked by significant revisions to major legislation and regulations.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Six Key Insights Into China Biotech's NewCo Model

    In the age of globalization, Chinese pharmaceutical companies are at the forefront of innovation and collaboration, seizing unprecedented development opportunities.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    China Plans To Establish A Drug Patent Linkage System

    China has proposed a new rule framing a drug patent linkage system that will have significant impact on multinational pharmaceutical companies doing business in China
    ChinaIntellectual Property
    Arnold & Porter
    Arnold & Porter
  • Article

    Supreme People's Court Issued Interpretation On Punitive Damages For Food And Drug Disputes

    The Supreme People's Court ("SPC") of the People's Republic of China ("PRC") has recently promulgated the Interpretation on Several Issues Concerning the Application of Law to the Trial of Cases of Disputes over Punitive Damages in Food and Drugs ("Interpretation"), taking effect from August 22, 2024.
    ChinaFood, Drugs, Healthcare, Life Sciences
    CMS
    CMS
  • Article

    Donations And Grants In China: Compliance Controls Beyond T&E

    Additionally, it may be worthwhile to understand the level of compliance controls employed by the intermediary to assess third-party compliance risks.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    速评《美国优先投资政策备忘录》对中国生物医药行业的潜在影响

    当地时间2025年2月21日,美国总统特朗普发布了一份名为《美国优先投资政策》(America First Investment Policy)的备忘录("备忘录")
    ChinaGovernment, Public Sector
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    China Released Draft Medical Device Law For Comments

    On August 28, 2024, the National Medical Products Administration (NMPA) released the Medical Device Administration Law (Draft for Comment)...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    A Brief Discussion On Biological Preservation And The Patentability Of Patent Applications Under Chinese Patent Law

    With the rapid development of biotechnology, the number of patent applications for biological materials such as microorganisms and cell lines has been on the rise. However, due to the unique characteristics of biological materials, they face many unique challenges in the process of patent protection
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    New Chinese Patent Law: What Does It Mean For Life Sciences Companies ?

    After more than three years of preparation work, the revised PRC Patent Law ("New Patent Law") was finally promulgated on 27 December 2008 and will enter into force on 1 October 2009.
    ChinaIntellectual Property
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    Growth and Opportunities in China's Medical Device Market.

    Overview of the development, segmentation, driving forces, and emerging opportunities within China's medical device market.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Acclime
    Acclime
  • Showing 161–180 of 332 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics